PolyPid Ltd. ( PYPD) - Key Metrics
PYPD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.35 | $0 | $0 |
| 2026Q1 | $0 | -$0.35 | $0 | $0 |
| 2025Q4 | $0 | -$0.41 | $0 | $0 |
| 2025Q3 | $0 | -$0.37 | $0 | $0 |
| 2025Q2 | $0 | -$0.78 | $0 | $0 |
PYPD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.63 |
| 2026Q1 | 0% | -3.13 |
| 2025Q4 | 0% | -2.65 |
| 2025Q3 | 0% | -2.26 |
| 2025Q2 | 0% | -1.13 |
PYPD
Price: $4.74
52 week price:
Earnings Per Share: -1.72 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 407700
Market Capitalization: 91.7 million